Re­silience pur­chas­es Ohio bio­man­u­fac­tur­ing site from As­traZeneca

Biotech man­u­fac­tur­ing pi­o­neer Re­silience said Tues­day af­ter­noon that it is pur­chas­ing an Ohio-based man­u­fac­tur­ing site from As­traZeneca and build­ing a new part­ner­ship with the UK-based phar­ma.

The fa­cil­i­ty is based in the town of West Chester, OH, just north of Cincin­nati. Re­silience will pro­duce “se­lect” As­traZeneca med­i­cines at the fa­cil­i­ty as part of the sup­ply agree­ment. The fi­nan­cial terms of the agree­ment weren’t dis­closed, but the deal is ex­pect­ed to close ear­ly next year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER